Microvascular damage (MD) occurring soon after primary percutaneous coronary intervention (PPCI) may reverse or remain sustained within the first week after ST-elevation myocardial infarction (STEMI). We investigated the incidence, determinants, and long-term clinical relevance of MD reversal after PPCI.
Introduction
After an acute ST-segment elevation myocardial infarction (STEMI), the goal of therapy is the timely and successful restoration of infarct-related artery (IRA) patency. However, benefits of prompt coronary re-canalization may be limited by the occurrence of microvascular damage (MD) 1 -4 that recognizes a multifactorial pathogenesis mainly related to ischaemia-re-perfusion injury and distal coronary microembolization.
Previous studies demonstrated that MD may be persistent (sustained MD) or reversible (reversible MD) in the first week after STEMI. 5 -8 Sustained MD is associated with unfavourable left ventricle (LV) remodelling, 9 whereas reversible MD not only influences the prevention of LV remodelling but it is also a major determinant of reverse LV remodelling. 10 Several studies have demonstrated that the incidence of MD remains high in STEMI patients despite timely successful revascularization, 1 -11 but little information is available on the incidence and main determinants of MD dynamic changes over time. In particular, no information is available on the long-term prognosis in STEMI patients with reversible MD. Thus, we analysed the AMICI (Acute Myocardial Infarction Contrast Imaging) multicentre study database 9, 10 to assess the incidence, determinants, and long-term clinical significance of MD reversal during the first week after primary percutaneous coronary intervention (PPCI) in a group of timely re-perfused STEMI patients.
Methods

Study population
Details of the AMICI study have been previously published. 8, 9 Briefly, consecutive patients referred to the catheterization laboratories of three study centres between January and November 2005, undergoing successful PPCI within 6 h of the onset of STEMI symptoms entered the acute myocardial infarction contrast imaging (AMICI) multi-centre study. The Ethical Committees of the three institutions involved approved the study, and all patients gave informed consent to participate in the study. Clinical characteristics of patients [age, sex, hypercholesterolaemia, diabetes, family history of coronary artery disease (CAD), hypertension, and smoke] were collected. Diabetes mellitus (DM) was considered present if this diagnosis and treatment, including diet, drugs, or insulin, had been given to the patient before hospital admission. Patients with transient hyperglicaemia without a previous history of diabetes were not included in the DM group. After re-perfusion, peak creatine kinase (CK) and early % ST-segment reduction were evaluated. Two-dimensional echocardiography, followed by a myocardial contrast study was performed within 24 h of coronary re-canalization (T1) and at pre-discharge (T2). Follow-up two-dimensional echocardiograms (2DE) was scheduled after 6 months (T3).
Echocardiography study
Two experienced observers without any knowledge of the patient identity analysed echocardiographic data; disagreement was resolved by consent. Images were randomized across time points and patients. Regional LV wall motion score index (RWMSI), end-diastolic and end-systolic LV volumes (LVEDV and LVESV), and LV ejection fraction (LVEF) were calculated as previously described. 9 -11 The percentage of the extent of wall motion abnormalities (WMA%), as an index of the infarct area, was also calculated by dividing the number of akinetic and dyskinetic segments by the total number of segments evaluated.
-11
Myocardial contrast echocardiography
The echocardiographic parameters of MD were assessed by real-time myocardial contrast echocardiography (MCE) using continuous infusion of Sonovue w (Bracco Imaging) as previously described. 8 -10 MD was semi-quantitatively calculated using a 17-segment model of the LV by assigning the following contrast scores: 1: homogeneous enhancement; 2: patchy enhancement; 3: no enhancement. A regional contrast score index (RCSI) was calculated by dividing the sum of the contrast scores for each dysfunctional segment by the number of dysfunctional segments analysed. MCE images were digitally stored to a magneto-optical disc. MD was defined as the presence of at least one segment with heterogeneous or absent contrast opacification. Best MCE images were selected for quantitative analysis of MD, as previously described. 9 -11 In brief, from native MCE images, the length of the endocardial border corresponding to the segment of the myocardium with no or poor opacification was measured in the two-, four-, and three-chamber views. The sum of three endocardial border length measurements defined the size of the perfusion defect. The following formula was used to assess the relative contrast defect length (CDL%): (total length of the residual contrast defect after re-perfusion)/(total length of endocardial borders) × 100. On the basis of our previously published 10 reproducibility analysis, changes in CDL% .5% were considered significant. 'reversible MD' was defined as a decrease in CDL% .5% from hospital admission to pre-discharge, whereas 'sustained MD' was defined as changes in CDL% ,5%. Persistent normal perfusion on admission and at predischarge was considered 'normal reflow'.
Percutaneous coronary intervention and medications
In all patients, PPCI and stenting of the IRA was performed according to the clinical protocol used at our institutions, as previously reported with more details. 9, 10 Glycoprotein IIB/IIIA inhibitors (0.25 mg/kg bolus plus infusion of 0.125 g/kg/min for 12 h) were always intravenously administered. Thrombolysis in myocardial infarction (TIMI) and myocardial blush grade (MBG) were semi-quantitatively scored as previously described and evaluated before and after re-perfusion. The number of coronary vessels showing significant CAD was calculated. Successful percutaneous coronary intervention (PCI) was defined as the restoration of the TIMI flow Grade 3 or 2 with residual stenosis of the culprit artery post-PCI ,20% in all patients.
Follow-up
After discharge, clinical follow-up was achieved at 6 months and a phone interview at 2 years. Major adverse cardiac events (MACE) were defined as cardiac death (defined as sudden death caused by acute myocardial infarction (AMI) or arrhythmia or heart failure), nonfatal AMI (typical chest pain and increased troponin I), and hospitalization for congestive heart failure. The diagnosis of heart failure was based on clinical symptoms (limitation of activity, fatigue, and dyspnoea), physical signs (oedema, elevated jugular venous pressure, rales, or third heart sound with gallop), or radiological evidence of pulmonary congestion. For purposes of survival analyses, only one event (the first which occurred) was tabulated for each patient.
Statistical analysis
Statistical analysis was performed using the SPSS software package for Windows 17.0 (SPSS Inc., Chicago, IL, USA). The sample size calculation was based on the following assumptions: alpha error: 0.05; beta error: 0.20, 85% of estimated percentage of event-free survival in reversible MD at 24 months, 30% in the difference of events incidence between groups with MD. On the basis of these assumptions, we calculated to recruit almost 33 patients per group.
Normally distributed variables were tested by two-tailed Student's t-test for paired or unpaired data, as appropriate, or by one-way analysis of variance (ANOVA) for more than two independent groups of data. The categorical variables were compared by x 2 or Fisher's exact test where appropriate. The statistical significance was set at P ≤ 0.05 (two-sided tests) and, for multiple testing, we used a statistical significance of P ≤ 0.01. A multivariable logistic regression analysis was conducted considering as a dependent variable the occurrence of reversible MD at the first week after re-perfusion. Among all risk factors and all clinical and angiographic parameters evaluated (age, sex, diabetes, smoke, Determinants of MD recovery after AMI hypercholesterolaemia, family history of CADs, % ST segment reduction, peak CK, time to re-perfusion, Killip Class, infarct site location, number of vessels disease, TIMI and Blush grade before and after re-perfusion, collateral flow 2 -3, thrombus score, percent of thrombus aspiration, concomitant medication, and pre-infarction angina), only the variables presenting a P-value ≤ 0.25 at univariable analysis were included in the model. The stepwise method with backward elimination was used and odds ratios (ORs) with 95% confidence intervals (CI) were calculated. The model was evaluated with the Hosmer and Lemeshow test.
The event-free survival curve for combined major cardiac events was constructed using the Kaplan -Meier method to assess the longterm clinical significance of in-hospital MD reversal. Statistical differences between curves were assessed by log-rank test.
Results
A total of 115 patients were enrolled, 5 of whom were lost to the 6-month follow-up. The remaining 110 patients were considered for the final analysis. The average time periods for T1, T2, and T3 were: 26 + 2 h, 8 + 2 days, and 190 + 20 days, respectively. A 2-year follow-up (26 + 2 months) with phone interview was obtained. No MACE occurred up to the 6-month follow-up. 9, 10 In 40 (36%) out of 110 patients, a completely normal perfusion was observed on admission and at pre-discharge (Group 1-normal reflow). However, despite successful and timely IRA re-canalization, the remaining 70 (64%) showed MD soon after re-perfusion. At pre-discharge, MD partially or totally reversed in 33 (48%) of them (Group 2-reversible MD), whereas a sustained MD was observed in the remaining 37 (52%; Group 3-sustained MD). The incidence of patients with one of these three perfusion patterns was similar (normal perfusion: 36%, reversible MD: 30%; sustained MD: 34 %; P ¼ 0.125).
Baseline clinical, angiographic, and echocardiographic characteristics of the three groups are listed in Table 1 . There were no significant differences between the three groups in terms of age, gender, peak CK, time to treatment, concomitant medications, pre-infarction angina, and risk factors, except for the incidence of diabetes which was significantly higher in patients with sustained MD. No differences in the use of intravenous insulin between groups were observed. However, patients with normal perfusion had a significantly lower percentage of anterior infarct site location, and higher % ST-segment reduction, while the number of vessels diseases, collateral flow, and percentage of thrombus aspiration were similar between groups. Finally, a significantly high percentage of TIMI and Blush Grades 2-3 before and after PCI was detected in patients with normal perfusion. At T1, there were no significant differences with regard to the initial regional LV dysfunctioning area (WMA%, RWMSI), LV volumes, LVEF, and the extent of MD (CDL%, RCSI) among patients with MD (Groups 2 and 3). Patients with normal reflow, on the contrary, had a significantly smaller LV dysfunctioning area and LV volumes, and a better LVEF than the others ( Table 1) . Changes in CDL%, LV volumes, regional LV dysfunction, and the LVEF over time within groups were reported in Table 2 . In normal reflow patients, baseline regional LV dysfunction significantly decreased over time, LV volumes gradually decreased with a significant LVEF improvement at follow-up. At pre-discharge, a 48% reduction in CDL% (P ¼ 0.0003) was observed in patients with 'reversible MD'; conversely by definition no significant changes were detected in the sustained MD group (P ¼ 0.29). The extent of the regional LV dysfunction area (WMA and RWMSI) was similar in patients with reversible or sustained MD; however, it decreased significantly only in patients with reversible MD. Similarly to Group 1, patients of Group 2 showed a gradual reduction in LV volumes with a significant improvement in the LVEF at follow-up. On the other hand, Group 3 patients showed a progressive significant increase in LV volumes with significant worsening of the LVEF.
Predictors of reversible microvascular damage
All clinical and angiographic parameters which entered in the multivariable final model to predict reversible MD are listed in Table 3 . The stepwise method with backward elimination showed that younger age (OR ¼ 0.9, P ¼ 0.04), shorter time to re-perfusion (OR ¼ 2.2, P ¼ 0.049), absence of family history of CAD (OR ¼ 2.8, P ¼ 0.044), and absence of diabetes (OR ¼ 7.6, P ¼ 0.010) were independently associated with reversible MD.
Two-year survival
Up to the 2-year follow-up, four patients (3.6%) had non-fatal re-infarction, nine (8.2%) were hospitalized for heart failure, and three (2.7%) had cardiac death. According to the Kaplan -Meier method, the 2-year cumulative combined events rate was significantly lower in patients with 'partially or totally reversible MD' when compared with patients with 'sustained MD' (log-rank test P ¼ 0.03; Figure 1 ).
Discussion
In the first report from the AMICI trial, we were able to demonstrate that the extent of MD on Day 1 after coronary re-perfusion is the most powerful independent predictor of LV remodelling after STEMI. 9 In the second report from the same trial, 10 we showed that the opposite phenomenon the so-called 'reverse LV remodelling' frequently occurs after STEMI and is strongly related to a relatively preserved microvascular perfusion within the infarct zone soon after re-perfusion or to the rapid MD repair occurring in the first week after STEMI. However, no information was previously available on the main determinants of changes over time of MD. The present study showed a surprisingly high occurrence (.60%) of microvascular dysfunction in STEMI patients treated according to the current guidelines. Further, this study confirms 5 -7 that MD may reverse 1 week after hospital admission in 50% of cases. However, this study shows for the first time that between several variables potentially influencing in-hospital MD reverse, only the absence of family history of CAD, younger age, shorter time to re-perfusion, and absence of diabetes are independent predictors of reversibility. Thus, the physiological repair of MD occurring after an ischaemic injury is strongly dependent on the interaction between a pre-existing microvascular dysfunction and the degree of MD potentially developing after infarct-related PCI. Finally, this study showed for the first time the strong clinical impact of MD recovery. This subset of patients had a high long-term event-free survival, likely related to the significant infarct size and LV volume reduction with a significant improvement of systolic function observed at follow-up.
Temporal evolution of microvascular damage after coronary re-canalization
Changes in microvascular perfusion after AMI have been previously observed by several studies; 14 has recently proposed to classify postischaemic MD as structural (sustained) or functional (reversible).
The sustained MD might be related to irreversible damage of cellular components of microvessel walls within the necrotic myocardium; conversely, the reversible MD appears related to resolution of potentially reversible mechanisms such as loss of endotheliummediated vasomotion, oedema, and cellular plugging in microvessels anatomically intact, distal microembolization. Recovery of MD may be related to spontaneous resolution of microvascular spasms and residual thrombosis, or transient impairment of coronary flow reserve or/and new angiogenesis phenomena. The reversibility of MD is an index of viability and is associated with LV functional improvement and reverse remodelling, which is an there is an amount of dysfunctioning myocardium initially not well perfused and then apparently not viable that may recover later. However, the mechanisms which promote the changes in MD are still not clear and remain under discussion.
Major determinants of microvascular damage recovery
Our data confirmed that MD frequently occurs after successful IRA re-canalization. 1 -4 However, as previously observed, 14 in half of these patients MD recovers in the first week after hospital admission. In the present study, we showed for the first time that between several factors potentially influencing MD repair only the absence of family history of CAD, younger age, shorter time to re-perfusion, and absence of diabetes are independent predictor of recovery. With advanced age, reactive changes in microvascular structure and function may occur inducing an increase in peripheral resistance and a reduction in the vasodilatory reserve. 15 MD is also more pronounced with longer time to treatment. We have recently demonstrated using cardiac MRI that the occurrence and the extent of microvascular obstruction are closely dependent on the time from the symptom onset to re-perfusion. 16 Thus, shorter time to re-perfusion seems to be an important determinant of MD repair. Finally, diabetes is the strongest determinant of changes in postischaemic microvascular dysfunction. The probability to have reversible MD is 7.6 times higher in patients without diabetes. It is well known that DM is strongly associated with increased cardiovascular morbidity and mortality in STEMI patients undergoing PCI. These patients have a lower incidence of spontaneous reflow before PCI which is correlated to worse post-PCI epicardial patency, 17 generally a larger infarction and poorer outcome after PCI. Two large clinical trials have recently showed that in patients undergoing PPCI, diabetes is independently associated with decreased myocardial re-perfusion. 18, 19 The authors explain these findings as an exaggeration of pre-existing microvascular disease which may be mediated by neuro-humoral and inflammatory mechanisms, and/or distal microembolization of thrombotic material. The enhancement of platelet reactivity and the reduction of responsiveness to anti-platelet therapy induce, in diabetic patients, a higher thrombus burden along with increased thrombogenicity which in part explains a lower incidence of spontaneous re-perfusion. 20 Also new angiogenesis could be reduced in diabetics. 21 In conclusion, all these factors have a great influence on the spontaneous recovery of MD occurring in the first week after AMI.
Other factors influencing microvascular damage recovery
Other factors may also contribute to MD repair. 4 Ischaemic preconditioning may play a protective role on microvascular flow. However, in our study, the incidence of pre-infarction angina was similar between groups. No patient was treated with nicorandil or sulfonylurea which commonly have an opposite effect on preconditioning. CAD severity, spontaneous re-perfusion, and gender may play a role in limiting MD. 4 In our study, blush and TIMI grade before PCI, CAD severity, and male gender were related to MD reverse, but they were not independent predictors. In particular, the incidence of left anterior descending disease was significantly lower in patients with normal reflow, but similar in patients with sustained or reversible MD (84 vs. 80%, ns). Probably, the influence of other stronger variables such as age, time to re-perfusion, and diabetes may reduce the effects of these factors. Finally distal microembolization after PPCI may play an important role in the pathogenesis of MD. We recently showed that thrombus aspiration may significantly reduce the incidence of MD as detected by MRI after primary PCI. 22 In the present study, thrombus aspiration was used in the majority of patients without any significant difference between groups (Table 1) . Thus, distal microembolization should not be responsible for the different temporal MD behaviour. As for other established risk factors such as hypertension, cigarette smoking, and dislypidaemia they did not enter nor at univariable neither at multivariable analysis for prediction of MD reversal, likely as a consequence of a large use of anti-hypertensive drugs and statins. The incidence of smokers was similar between groups. Finally, MD repair was independent of ischaemia severity since infarct size was similar in the two different patterns of in-hospital MD changes.
Study limitations
Although our results have been collected in a multi-centre trial, they might need to be confirmed in larger longitudinal studies.
Patients enrolled in this study were optimally treated, thus, the key role of time to re-perfusion, age, and diabetes in favouring reversible MD in high-risk STEMI patients suboptimally treated cannot be derived. In particular, the persistence of IRA occlusion, the extent of collateral circulation, and no use of IIB/IIIA Glycoprotein should play too an important role in inducing irreversible MD. Thus, our results cannot be transferred to the STEMI population in general. However, the multi-centre design of the study Figure 1 2-year probability of cumulative event-free survival in sustained as compared to reversible MD group.
Determinants of MD recovery after AMI adds strength to the results and the data set collected allows drawing a conclusion that is statistically significant. Microvascular perfusion was assessed on Day 1 after re-perfusion and at pre-discharge, thus no information may be derived from this study on longer term changes of MD.
Finally, MCE was used in the present study because it was less expensive compared with other techniques for exploring microvascular perfusion, such as MRI or single photon emission computed tomography, but with similar diagnostic accuracy. 23 
Conclusions
In conclusion, in this multi-centre cohort of patients, we confirmed that MD frequently occurs after successful IRA re-canalization, and for the first time, we assessed major determinants and the clinical impact of reversible MD. Thus, the non-invasive serial evaluation of MD with MCE is a powerful tool for correctly stratifying the risk in STEMI patients after successful PCI.
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